Reuters: J&J, FDA warn of liver risk with HIV drug patients

[NaDiNe]

J&J, FDA warn of liver risk with HIV drug patients
      

WASHINGTON (Reuters) - Johnson & Johnson and the U.S. Food and Drug Administration warned of reported liver damage and death in patients taking the company's HIV drug Prezista, according to a letter released on Wednesday.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login